PTC Therapeutics, Inc. (PTCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.04B |
| Enterprise Value | 5.55B |
| P/E Ratio | -138.8 |
| PEG Ratio | 0.91 |
| Price/Sales Ratio | 5.63 |
| Price/Book Ratio | -34.14 |
| Enterprise/Revenue | 5.28 |
| Enterprise/EBITDA | 30.68 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.04 |
| Operating Margin | 0.12 |
| Return On Assets | -0.01 |
| Return On Equity | 0.22 |
| Revenue | 1.73B |
| Revenue/Share | 12.15 |
| Gross Profit | 1.66B |
| EBITDA | 887.66M |
| Net Income | 682.64M |
| Diluted EPS | 7.78 |
| Total Cash | 2.23B |
| Total Cash/Share | 26.85 |
| Total Debt | 696.47M |
| Total Debt/Equity | -4.21 |
| Current Ratio | 3.39 |
| Book Value Per Share | -1.99 |
| 52-Week Change | 30.16 |
| 52-Week High | 90.87 |
| 52-Week Low | 43.18 |
| Moving Average 50 Days | 77.14 |
| Moving Average 200 Days | 73.11 |
| Average Volume | 1.84M |
| Shares Outstanding | 83.46M |
| % Held by Institutions | 118.35 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |